Cerevel Therapeutics Hldg Inc
(CERE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -166,279 | -104,220 | -50,981 | -152,142 | -118,965 |
| Depreciation Amortization | 1,644 | 664 | 63 | 397 | 336 |
| Accounts payable and accrued liabilities | 1,874 | 1,485 | 3,176 | 1,417 | 581 |
| Other Working Capital | 11,282 | 7,446 | 8,123 | 17,707 | 17,740 |
| Other Operating Activity | 25,677 | 12,599 | 3,201 | 14,819 | 24,209 |
| Operating Cash Flow | $-125,802 | $-82,026 | $-36,418 | $-117,802 | $-76,099 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9,431 | -8,243 | -4,660 | -18,892 | -11,341 |
| Investing Cash Flow | $-9,431 | $-8,243 | $-4,660 | $-18,892 | $-11,341 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 15,625 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 390,036 | 2,571 | 742 | N/A | N/A |
| Other Financing Activity | 15,625 | 31,135 | 0 | 440,835 | 20,766 |
| Financing Cash Flow | $421,286 | $33,706 | $742 | $440,835 | $20,766 |
| Beginning Cash Position | 387,823 | 387,823 | 387,823 | 83,682 | 83,682 |
| End Cash Position | 673,876 | 331,260 | 347,487 | 387,823 | 17,008 |
| Net Cash Flow | $286,053 | $-56,563 | $-40,336 | $304,141 | $-66,674 |
| Free Cash Flow | |||||
| Operating Cash Flow | -125,802 | -82,026 | -36,418 | -117,802 | -76,099 |
| Capital Expenditure | -9,431 | -8,243 | -4,660 | -18,892 | -11,341 |
| Free Cash Flow | -135,233 | -90,269 | -41,078 | -136,694 | -87,440 |